Correspondence 0001213900-24-023553 from AKANDA CORP. (AKAN)
AKANDA CORP.
Date: March 18, 2024 · CIK: 0001888014 · Accession: 0001213900-24-023553
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277182
Letter
VIA EDGAR Division of Corporation Finance Office of Life Sciences Attention: Tamika Sheppard Re: Akanda Corp. (the “Company”) Registration Statement on Form F-1 File No. 333-277182 (the “Registration Statement”)
Dear Ms. Sheppard:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as the representative of the several underwriters of the Company’s proposed public offering, we wish to advise you that we hereby join with the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30pm, Eastern Time, on March 19, 2024, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus, dated March 11, 2024, through the date hereof, to prospective underwriters, institutional investors, dealers and others as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will continue to comply, and we have been informed by the participating underwriters and dealers that they have complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Please contact Joseph E. Segilia, Esq., Sullivan & Worcester LLP, counsel of the representative of the underwriters, at (212)660-3027 to provide notice of effectiveness, or if you have any questions or concerns regarding the foregoing. We appreciate your assistance in this matter.
[Signature page follows]
Very truly yours,
As representative of the underwriters
Show Raw Text
CORRESP
1
filename1.htm
Univest Securities LLC
75 Rockefeller Plaza, Suite 1838
New York, NY 10019
March 18, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
Attention: Tamika Sheppard
Re:
Akanda Corp. (the “Company”)
Registration Statement on Form F-1
File No. 333-277182 (the “Registration Statement”)
Dear Ms. Sheppard:
In accordance with Rule
461 under the Securities Act of 1933, as amended (the “Act”), and as the representative of the several underwriters
of the Company’s proposed public offering, we wish to advise you that we hereby join with the Company’s request that the effective
date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30pm, Eastern Time, on
March 19, 2024, or as soon thereafter as practicable.
Pursuant to Rule 460 under
the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus, dated March 11, 2024, through the
date hereof, to prospective underwriters, institutional investors, dealers and others as appears to be reasonable to secure adequate distribution
of the Preliminary Prospectus.
We, the undersigned, as
representatives of the several underwriters, have complied and will continue to comply, and we have been informed by the participating
underwriters and dealers that they have complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities
Exchange Act of 1934, as amended.
Please contact Joseph E.
Segilia, Esq., Sullivan & Worcester LLP, counsel of the representative of the underwriters, at (212)660-3027 to provide notice of
effectiveness, or if you have any questions or concerns regarding the foregoing. We appreciate your assistance in this matter.
[Signature page follows]
Very truly yours,
As representative of the underwriters
Univest Securities, LLC
By:
/s/ Brad Richmond
Name:
Brad Richmond
Title:
COO and Co-Head of Investment Banking
cc:
Joseph E. Segilia, Esq., Sullivan & Worcester LLP